Cheav Sotheara sold $195K of ACMR
Cheav Sotheara (See remarks) sold 2,384 shares of ACM Research, Inc. (ACMR) at $81.73 ($0.19M total) on 2026-06-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure may slightly influence sentiment, but 10b5-1 typically implies the trades were scheduled in advance and are less informative about new private information.
Market read
A single disclosed 10b5-1 sale by an officer; generally low incremental trading signal absent other catalysts.
What to watch
The article provides only the sale details; it does not indicate whether there were concurrent buys, changes in total insider ownership, or any new operational/company catalysts.
Background
This is an SEC Form 4 insider transaction (officer/direct) reporting an open-market sale executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
ACM Research officer Cheav Sotheara sold $194.8K of ACMR shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Limited immediate impact; any reaction is likely muted unless accompanied by other company-specific news.
The filing is an ownership-change disclosure with explicit 10b5-1 pre-arranged plan, reducing interpretive weight versus discretionary selling.
Market effects
No clear sector read-through from a single officer 10b5-1 sale.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with management’s view of near-term valuation or liquidity needs.
Key entities
- issuerACM Research, Inc.
Subject of the Form 4 insider transaction; officer Cheav Sotheara sold shares under a 10b5-1 plan.
